389 related articles for article (PubMed ID: 18489400)
1. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.
Guerrero-Romero F; Rascón-Pacheco RA; Rodríguez-Morán M; de la Peña JE; Wacher N
Eur J Clin Invest; 2008 Jun; 38(6):389-96. PubMed ID: 18489400
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridemia is associated with development of metabolic glucose disorders, irrespective of glucose and insulin levels: a 15-year follow-up study.
Guerrero-Romero F; Rodríguez-Moran M
Eur J Intern Med; 2014 Mar; 25(3):265-9. PubMed ID: 24507408
[TBL] [Abstract][Full Text] [Related]
3. [The distributive characteristics of impaired glucose metabolism subcategories in Chinese adult population].
Yang ZJ; Yang WY; Li GW;
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2128-31. PubMed ID: 14720420
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
5. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
Love-Osborne K; Butler N; Gao D; Zeitler P
Pediatr Diabetes; 2006 Aug; 7(4):205-10. PubMed ID: 16911007
[TBL] [Abstract][Full Text] [Related]
6. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
Alvarsson M; Hilding A; Ostenson CG
Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
[TBL] [Abstract][Full Text] [Related]
7. Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran.
Janghorbani M; Amini M
Diabetes Metab Res Rev; 2009 Nov; 25(8):748-55. PubMed ID: 19862775
[TBL] [Abstract][Full Text] [Related]
8. Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study.
Chaput JP; Després JP; Bouchard C; Astrup A; Tremblay A
Sleep Med; 2009 Sep; 10(8):919-24. PubMed ID: 19332380
[TBL] [Abstract][Full Text] [Related]
9. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
[TBL] [Abstract][Full Text] [Related]
10. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
Guerrero-Romero F; Rodríguez-Morán M
Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
[TBL] [Abstract][Full Text] [Related]
11. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
Gerstein HC; Santaguida P; Raina P; Morrison KM; Balion C; Hunt D; Yazdi H; Booker L
Diabetes Res Clin Pract; 2007 Dec; 78(3):305-12. PubMed ID: 17601626
[TBL] [Abstract][Full Text] [Related]
12. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
[TBL] [Abstract][Full Text] [Related]
13. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome.
Simmons D; Joshi S; Shaw J
Diabetes Res Clin Pract; 2010 Feb; 87(2):261-6. PubMed ID: 20004036
[TBL] [Abstract][Full Text] [Related]
14. Incidence of type 2 diabetes in southern Spain (Pizarra Study).
Soriguer F; Rojo-Martínez G; Almaraz MC; Esteva I; Ruiz de Adana MS; Morcillo S; Valdés S; García-Fuentes E; García-Escobar E; Cardona I; Gomez-Zumaquero JM; Olveira-Fuster G
Eur J Clin Invest; 2008 Feb; 38(2):126-33. PubMed ID: 18226046
[TBL] [Abstract][Full Text] [Related]
15. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
16. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
17. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.
Magliano DJ; Barr EL; Zimmet PZ; Cameron AJ; Dunstan DW; Colagiuri S; Jolley D; Owen N; Phillips P; Tapp RJ; Welborn TA; Shaw JE
Diabetes Care; 2008 Feb; 31(2):267-72. PubMed ID: 17989310
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.
Forouhi NG; Luan J; Hennings S; Wareham NJ
Diabet Med; 2007 Feb; 24(2):200-7. PubMed ID: 17257284
[TBL] [Abstract][Full Text] [Related]
19. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes.
van Genugten RE; Utzschneider KM; Tong J; Gerchman F; Zraika S; Udayasankar J; Boyko EJ; Fujimoto WY; Kahn SE;
Diabetes; 2006 Dec; 55(12):3529-35. PubMed ID: 17130501
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.
Kang HW; Kim DJ; Lee MS; Kim KW; Lee MK
Diabetes Res Clin Pract; 2005 Aug; 69(2):180-7. PubMed ID: 16005368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
